After you upload your verification photos, the GLP-1 order process moves into clinical review. This stage is an important part of the GLP-1 review process and helps confirm that treatment such as Wegovy® or Mounjaro® is safe and appropriate for you.
This review makes sure your GLP-1 treatment is suitable based on your medical history, current medications, and Summary Care Record (SCR).
Overview
This article explains:
What happens during the GLP-1 clinical review process
Why additional information may be requested
Why a GLP-1 prescription may not be approved
Typical GLP-1 review and delivery timelines
Step 1: Screening of verification photos and Previous use evidence
Your photo ID, weight verification photos, and any Previous Use Evidence (PUE) are checked first.
When your verification photos and PUE meet the required standards, your GLP-1 order moves forward in the clinical review process.
Only GLP-1 orders that pass this screening stage continue to clinician review.
Step 2: Clinical Team review
Once screening is complete, a qualified clinician reviews your order as part of the GLP-1 prescribing process.
What happens during clinical review?
During review of Wegovy® or Mounjaro®, the clinician will:
Confirm the GLP-1 medication requested
Review your current medications
Consider your medical history and health conditions
Check your Summary Care Record (SCR) for safety concerns
This careful clinical review process ensures your GLP-1 treatment is safe and appropriate before a prescription is issued.
Step 3: Request for additional information (if needed)
Sometimes the Clinical Team needs more details before completing the GLP-1 review process.
Why additional information may be requested
Extra information may be needed to:
Clarify medical history or medication details
Confirm previous GLP-1 treatment
Check something identified in the Summary Care Record
Ensure prescribing is safe and responsible
If additional information is required, your GLP-1 order will remain on hold until the review process is complete.
Why a GLP-1 prescription may not be approved
Not every GLP-1 request can be safely prescribed.
A prescription for Wegovy® or Mounjaro® may not be approved if:
Eligibility criteria are not met
Your medical history or medications make treatment unsafe
BMI or verification evidence does not support prescribing
Important information is missing or cannot be confirmed
Treatment would not be clinically appropriate
These decisions are made to protect patient safety.
How long does the GLP-1 review process take?
Typical timelines for GLP-1 orders are:
Clinical review and dispatch: usually 1–4 working days after screening is complete
Delivery: usually 1–3 working days after dispatch
The review process may take longer if additional information is needed.
What happens next?
If your GLP-1 treatment is approved, your order moves to dispatch.
If the treatment is not suitable, the outcome is shared by email with further information.
Key takeaway
After you upload your verification photos, your GLP-1 order enters the clinical review process. The Clinical Team checks safety and suitability before prescribing. Some orders require additional information, and review timelines may vary.
If you still need help after reviewing the information above, additional assistance is available.
